Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Philadelphia, Pennsylvania 25 trials found
New Search
Filter
Trial Phase
Study Type
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
NAINTERVENTIONAL Philadelphia, Pennsylvania
RECRUITING
CTNNA1 Familial Expansion Study
N/AOBSERVATIONAL Philadelphia, Pennsylvania
RECRUITING
ATEMPT 2.0: Adjuvant T-DM1 vs TH
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Childhood Cancer Survivor Study
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
N/AOBSERVATIONAL Boston, Massachusetts +4 more
RECRUITING
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
NAINTERVENTIONAL Philadelphia, Pennsylvania
RECRUITING
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
The PREDICT Registry:
N/AOBSERVATIONAL Scottsdale, Arizona +4 more
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Stanford, California +4 more
RECRUITING
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NAINTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
NAINTERVENTIONAL Philadelphia, Pennsylvania
RECRUITING
[18F] F-GLN by PET/CT in Breast Cancer
PHASE1INTERVENTIONAL Philadelphia, Pennsylvania
RECRUITING
Pan Tumor Rollover Study
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Prospective Breast Cancer Biospecimen Collection
N/AOBSERVATIONAL Philadelphia, Pennsylvania
RECRUITING
Autoimmunity After Checkpoint Blockade
N/AOBSERVATIONAL Philadelphia, Pennsylvania
RECRUITING
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
PHASE2INTERVENTIONAL Stamford, Connecticut +4 more
RECRUITING
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
PHASE2INTERVENTIONAL Philadelphia, Pennsylvania
RECRUITING
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
PHASE2INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
Evaluation of Grief Therapy Approaches for Bereaved Parents
NAINTERVENTIONAL Stanford, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type